1 / 4

Contraceptives Market is progressing at a CAGR of 6.34% over the forecast period 2020-2026

Favourable regulatory scenario in developed nations, growing inclination towards planned delayed pregnancy, high unmet contraceptive needs in developing economies are the factors driving the contraceptives market growth.<br><br>Rising public programs by governments to raise awareness about unwanted pregnancy and rising population would generate huge demand for contraceptives during the forecast period 2020-2026.<br><br>Increase in number of women who are postponing motherhood as they prioritize their careers is the major driving factor for the market development.<br><br>Request Free Sample @ https://www.oganalysis.com/sample/217702<br><br>Pills are the most common alternative as women increasingly prefer user dependent methods over reversible contraceptives that work fast.<br><br>Increase in youth population or early pregnancy to raise patient demand and contraceptive acceptance rates would fuel the market growth over the estimated period of time.<br><br>Browse Contraceptives Market, Research Report @ https://www.oganalysis.com/industry-reports/217702/contraceptives-market<br><br>Regional aspects of contraceptives market growth<br><br>North America to hold the major market share owing to the presence of sophisticated healthcare facilities, increase in demand for contraception for avoiding unintended pregnancies, and favorable regulatory scenario.<br><br>The provision of sexual health services and thus more people using these facilities to receive contraception and related information would boost the regional share of revenue.<br><br>Increasing trend of delayed pregnancy among women in the developing and developed economies would result in increased use of contraceptives, boosting the market growth.<br><br>Further, in Asia Pacific increased prevalence of STDs, awareness-raising campaigns of contraception and other policy initiatives in developing countries such as India and others to drive the market growth.<br><br>In addition, favorable family planning legislation along with other programs for reimbursement such as the AIDS care program to have a positive effect on market revenue in this region.<br><br>Request for Special Discount on Contraceptives Market @ https://www.oganalysis.com/discount/217702<br><br>Key players participating in the growth of contraceptives market share<br><br>New unveilings of drugs, investments by the key firms to propel the contraceptives market growth. For instance, in 2020, Mayne Pharma submitted a new drug application to the US Food and Drug Administration (FDA) for its E4/DRSP oral contraceptive.<br><br>Further, in 2020, Agile Therapeutics Inc. declared that the U.S. Food and Drug Administration (FDA) has approved the TWIRLA a method of contraception.<br><br>In addition, in 2019, Nurx partnered with Power to Decide to prevent unplanned pregnancy. Besides, Nurx provided a $10,000 donation to Power to Decide's BCBenefits.<br><br>Furthermore, in 2018, after receiving approval from the US Food and Drug Administration (USFDA), Lupin launched Drospirenone, Ethinyl Estradiol, Levomefolate Calcium tablets and Levomefolate Calcium tablets to prevent pregnancy.<br><br>Additionally, the US FDA allowed the marketing of NATURAL CYCLES medical application(App) in the year 2018 that can be used as a method for contraception to prevent pregnancy.<br><br>Moreover, in 2018, Aurobindo Pharma launched MILI and TRI-MILI oral contraceptives tablets for the womens to avoid pregnancy. Also, in the same year Mylan N.V launched generic YAZ oral contraceptives drugs.<br><br>Key players of contraceptives market include Allergan Plc, Bayer Corporation, Cooper Surgical, Inc., Church & Dwight Co., Inc., Mayer Laboratories, Inc., Merck & Co. Inc., Pfizer, Reckitt Benckiser Group Plc, Teva Pharmaceuticals Industries Ltd., and The Female Health Company/Veru Inc. among others.<br><br>Ambarish Ram<br>OG Analysis<br> 91 73370 13757<br>email us @sales@oganalysis.com

OGANALYSIS123
Télécharger la présentation

Contraceptives Market is progressing at a CAGR of 6.34% over the forecast period 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 29/04/2020 Contraceptives Market is progressing at a CAGR of 6.34% over the forecast period 2020-2026 ISSUED BY OG ANALYSIS Contraceptives Market is progressing at a CAGR of 6.34% over the forecast period 2020- 2026 Global Contraceptives Market 2020 Contraceptives Market Size, Share and Trend Analysis Report to 2026- Growth Opportunities and Competitive Analysis UNITED STATES, April 20, 2020 /EINPresswire.com/ -- Favourable regulatory scenario in developed nations, growing inclination towards planned delayed pregnancy, high unmet contraceptive needs in developing economies are the factors driving the contraceptives market growth. Rising public programs by governments to raise awareness about unwanted pregnancy and rising population would generate huge demand for contraceptives during the forecast period 2020-2026. Increase in number of women who are postponing motherhood as they prioritize their careers is the major driving factor for the market development. Request Free Sample @ https://www.oganalysis.com/sample/217702 Pills are the most common alternative as women increasingly prefer user dependent methods over reversible contraceptives that work fast. Increase in youth population or early pregnancy to raise patient demand and contraceptive acceptance rates would fuel the market growth over the estimated period of time. Logged in as: marketing@oganalysis.com · My Newsroom · My Press Releases · My Account · Logout https://www.einpresswire.com/article/515013788/contraceptives-market-is-progressing-at-a-cagr-of-6-34-over-the-forecast-period-2020-2026 1/4

  2. 29/04/2020 Contraceptives Market is progressing at a CAGR of 6.34% over the forecast period 2020-2026 Browse Contraceptives Market, Research Report @ https://www.oganalysis.com/industry- reports/217702/contraceptives-market Regional aspects of contraceptives market growth North America to hold the major market share owing to the presence of sophisticated healthcare facilities, increase in demand for contraception for avoiding unintended pregnancies, and favorable regulatory scenario. The provision of sexual health services and thus more people using these facilities to receive contraception and related information would boost the regional share of revenue. Increasing trend of delayed pregnancy among women in the developing and developed economies would result in increased use of contraceptives, boosting the market growth. Further, in Asia Pacific increased prevalence of STDs, awareness-raising campaigns of contraception and other policy initiatives in developing countries such as India and others to drive the market growth. In addition, favorable family planning legislation along with other programs for reimbursement such as the AIDS care program to have a positive effect on market revenue in this region. Request for Special Discount on Contraceptives Market @ https://www.oganalysis.com/discount/217702 Key players participating in the growth of contraceptives market share New unveilings of drugs, investments by the key firms to propel the contraceptives market growth. For instance, in 2020, Mayne Pharma submitted a new drug application to the US Food and Drug Administration (FDA) for its E4/DRSP oral contraceptive. Further, in 2020, Agile Therapeutics Inc. declared that the U.S. Food and Drug Administration (FDA) has approved the TWIRLA a method of contraception. In addition, in 2019, Nurx partnered with Power to Decide to prevent unplanned pregnancy. Besides, Nurx provided a $10,000 donation to Power to Decide's BCBenefits. Furthermore, in 2018, after receiving approval from the US Food and Drug Administration (USFDA), Lupin launched Drospirenone, Ethinyl Estradiol, Levomefolate Calcium tablets and Levomefolate Calcium tablets to prevent pregnancy. Additionally, the US FDA allowed the marketing of NATURAL CYCLES medical application(App) in the year 2018 that can be used as a method for contraception to prevent pregnancy. Moreover, in 2018, Aurobindo Pharma launched MILI and TRI-MILI oral contraceptives tablets for the womens to avoid pregnancy. Also, in the same year Mylan N.V launched generic YAZ oral contraceptives drugs. Key players of contraceptives market include Allergan Plc, Bayer Corporation, Cooper Surgical, Inc., Church & Dwight Co., Inc., Mayer Laboratories, Inc., Merck & Co. Inc., Pfizer, Reckitt Benckiser Group Plc, Teva Pharmaceuticals Industries Ltd., and The Female Health Company/Veru Inc. among others. Ambarish Ram OG Analysis +91 73370 13757 email us here Visit us on social media: Logged in as: marketing@oganalysis.com · My Newsroom · My Press Releases · My Account · Logout https://www.einpresswire.com/article/515013788/contraceptives-market-is-progressing-at-a-cagr-of-6-34-over-the-forecast-period-2020-2026 2/4

  3. 29/04/2020 Contraceptives Market is progressing at a CAGR of 6.34% over the forecast period 2020-2026 Facebook Twitter LinkedIn Share on Facebook · Twitter · LinkedIn Distribution channels: Banking, Finance & Investment Industry, Business & Economy, Companies, Healthcare & Pharmaceuticals Industry, Retail EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors. Press Contact Share This Story Company Details Ambarish Ram OG Analysis +91 73370 13757 email us here Facebook Twitter LinkedIn Print PDF OG Analysis Lakshmi Sai Damam, Hi-Tech City Hyderabad, 500081 India +91 73370 13757 Visit Website Visit Newsroom About OG Analysis has been a trusted research partner for 10+ years delivering most reliable analysis, information and innovative solutions. OG Analysis is one of the leading players in market research industry serving 980+ companies across multiple industry verticals. Our core client centric approach comprehends client requirements and provides actionable insights that enable users to take informed decisions. Contact Us: Anil Kumar Phone: +91-7337 01 3757 Email: sales@oganalysis.com More From This Author Intravenous Immunoglobulin (IVIG) Market to grow with a CAGR of 7.2% over the forecast period 2020-2026 Biologics Market to emerge with a robust growth of 10.4% CAGR over 2020-2026 Animal Health Market to grow with a CAGR of 5.87% during the estimated time period 2020-2026 View All Stories From This Author Logged in as: marketing@oganalysis.com · My Newsroom · My Press Releases · My Account · Logout https://www.einpresswire.com/article/515013788/contraceptives-market-is-progressing-at-a-cagr-of-6-34-over-the-forecast-period-2020-2026 3/4

  4. 29/04/2020 Contraceptives Market is progressing at a CAGR of 6.34% over the forecast period 2020-2026 Logged in as: marketing@oganalysis.com · My Newsroom · My Press Releases · My Account · Logout https://www.einpresswire.com/article/515013788/contraceptives-market-is-progressing-at-a-cagr-of-6-34-over-the-forecast-period-2020-2026 4/4

More Related